The content on this site is intended for healthcare professionals only
ECCO 15 - ESMO 34 News 20-21 September, 2009
The Oncopolicy Roundtable: ECCO's President and special guests highlight key issues
ECCO 15 - ESMO 34 Chairs: Why join us in Berlin?
AACR 2009: Common genetic variations and predisposition to cancer
AACR 2009: 100 years of AACR
Bacteria as agents to initiate potent anti-tumour activity
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
S. Croce General Hospital
Cetuximab and docetaxal for squamous cell cancer of the head and neck, from ASCO 2008
